Almac Announces $250 Million Global Expansion Plans
Almac is committed to re-investing all profits back into its business and announced a $250 million global capital investment plan to meet increase client demand over the next three years which will take place in existing Almac locations. Their current employee numbers for the company are at over 6,500 and a global recruitment used with the expansion budget will increase the total number to over 8,000 over the next three years. The expansion will ensure that the company remains as the global leaders in their industry and give their clients as well as the patients who received the therapeutics the best that Almac has to offer.
Read more about this news release here.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
